Patents by Inventor Grant M. Hatch

Grant M. Hatch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for neuroprotection and treatment of neurodegeneration
    Patent number: 11160776
    Abstract: Compositions for neuroprotection and treatment of neurodegeneration and methods of administering same. In particular, the present invention relates to compositions and methods for preventing or reducing neurodegeneration, such as neurodegeneration caused by Huntington's disease, including administering a daily dose of a composition including an effective amount of creatine hydrochloride to a patient in need thereof. The methods of the present invention allow for lower dosages of supplementation as compared to creatine monohydrate while retaining all of the desired biological effects of creatine supplementation.
    Type: Grant
    Filed: March 9, 2020
    Date of Patent: November 2, 2021
    Assignee: Vireo Systems, Inc.
    Inventors: Mark C. Faulkner, Donald W. Miller, Grant M. Hatch
  • COMPOSITIONS AND METHODS FOR NEUROPROTECTION AND TREATMENT OF NEURODEGENERATION
    Publication number: 20200316000
    Abstract: Compositions for neuroprotection and treatment of neurodegeneration and methods of administering same. In particular, the present invention relates to compositions and methods for preventing or reducing neurodegeneration, such as neurodegeneration caused by Huntington's disease, including administering a daily dose of a composition including an effective amount of creatine hydrochloride to a patient in need thereof. The methods of the present invention allow for lower dosages of supplementation as compared to creatine monohydrate while retaining all of the desired biological effects of creatine supplementation.
    Type: Application
    Filed: March 9, 2020
    Publication date: October 8, 2020
    Applicant: Vireo Systems, Inc.
    Inventors: Mark C. Faulkner, Donald W. Miller, Grant M. Hatch
  • Compositions and methods for neuroprotection and treatment of neurodegeneration
    Patent number: 10583105
    Abstract: Compositions for neuroprotection and treatment of neurodegeneration and methods of administering same. In particular, the present invention relates to compositions and methods for preventing or reducing neurodegeneration, such as neurodegeneration caused by Huntington's disease, including administering a daily dose of a composition including an effective amount of creatine hydrochloride to a patient in need thereof. The methods of the present invention allow for lower dosages of supplementation as compared to creatine monohydrate while retaining all of the desired biological effects of creatine supplementation.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: March 10, 2020
    Assignee: Vireo Systems, Inc.
    Inventors: Mark C. Faulkner, Donald W. Miller, Grant M. Hatch
  • COMPOSITIONS AND METHODS FOR NEUROPROTECTION AND TREATMENT OF NEURODEGENERATION
    Publication number: 20190224151
    Abstract: Compositions for neuroprotection and treatment of neurodegeneration and methods of administering same. In particular, the present invention relates to compositions and methods for preventing or reducing neurodegeneration, such as neurodegeneration caused by Huntington's disease, including administering a daily dose of a composition including an effective amount of creatine hydrochloride to a patient in need thereof. The methods of the present invention allow for lower dosages of supplementation as compared to creatine monohydrate while retaining all of the desired biological effects of creatine supplementation.
    Type: Application
    Filed: April 1, 2019
    Publication date: July 25, 2019
    Applicant: Vireo Systems, Inc.
    Inventors: Mark C. Faulkner, Donald W. Miller, Grant M. Hatch
  • Compositions and methods for neuroprotection and treatment of neurodegeneration
    Patent number: 10245245
    Abstract: Compositions for neuroprotection and treatment of neurodegeneration and methods of administering same. In particular, the present invention relates to compositions and methods for preventing or reducing neurodegeneration, such as neurodegeneration caused by Huntington's disease, including administering a daily dose of a composition including an effective amount of creatine hydrochloride to a patient in need thereof. The methods of the present invention allow for lower dosages of supplementation as compared to creatine monohydrate while retaining all of the desired biological effects of creatine supplementation.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: April 2, 2019
    Assignee: Vireo Systems, Inc.
    Inventors: Mark C. Faulkner, Donald W. Miller, Grant M. Hatch
  • COMPOSITIONS AND METHODS FOR NEUROPROTECTION AND TREATMENT OF NEURODEGENERATION
    Publication number: 20160303061
    Abstract: Compositions for neuroprotection and treatment of neurodegeneration and methods of administering same. In particular, the present invention relates to compositions and methods for preventing or reducing neurodegeneration, such as neurodegeneration caused by Huntington's disease, including administering a daily dose of a composition including an effective amount of creatine hydrochloride to a patient in need thereof. The methods of the present invention allow for lower dosages of supplementation as compared to creatine monohydrate while retaining all of the desired biological effects of creatine supplementation.
    Type: Application
    Filed: April 20, 2016
    Publication date: October 20, 2016
    Applicant: Vireo Systems, Inc.
    Inventors: Mark C. Faulkner, Donald W. Miller, Grant M. Hatch